R. Cerveira

Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP

L. Goulart, M. Queiroz, A. Vallinoto, 2020, BMC Infectious Diseases.

Low Annexin A1 level in HTLV-1 infected patients might be a potential 1 biomarker for the clinical progression and diagnosis of HAM/TSP 2

L. Goulart, M. Queiroz, M. Sousa, 2020 .

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

A. Cagigi, K. Loré, S. Ols, 2022, Molecular Therapy - Methods & Clinical Development.

Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques

A. Cagigi, F. Nimmerjahn, K. Loré, 2023, bioRxiv.